- Report
- February 2024
- 80 Pages
North America
From €4614EUR$4,750USD£3,980GBP
- Report
- July 2023
- 332 Pages
United States
From €7765EUR$7,995USD£6,699GBP
- Report
- July 2023
- 332 Pages
United States
From €7765EUR$7,995USD£6,699GBP
- Report
- April 2023
- 105 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- March 2023
- 100 Pages
Global
From €2671EUR$2,750USD£2,304GBP
- Report
- January 2022
- 60 Pages
Global
From €3836EUR$3,950USD£3,310GBP
- Report
- January 2022
- 200 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- August 2022
- 116 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- August 2020
- 115 Pages
Global
From €4128EUR$4,250USD£3,561GBP
- Report
- August 2020
- 75 Pages
Asia Pacific
From €3642EUR$3,750USD£3,142GBP
- Report
- May 2021
- 40 Pages
Global
€1280EUR$1,318USD£1,104GBP
- Drug Pipelines
- July 2020
- 117 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- October 2020
- 73 Pages
Europe
From €1457EUR$1,500USD£1,257GBP
- Report
- December 2021
- 44 Pages
Global
From €3880EUR$3,995USD£3,347GBP
- Clinical Trials
- October 2020
- 327 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Clinical Trials
- May 2020
- 308 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Clinical Trials
- December 2019
- 168 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Drug Pipelines
- March 2021
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- April 2023
- 147 Pages
Global
From €5827EUR$5,999USD£5,026GBP
- Report
- February 2024
- 180 Pages
Global
From €5341EUR$5,499USD£4,607GBP
Dysmenorrhea, also known as painful periods, is a common condition experienced by women during menstruation. It is characterized by cramping, abdominal pain, and other symptoms such as nausea, vomiting, and diarrhea. Dysmenorrhea can range from mild to severe and can have a significant impact on a woman's quality of life. Treatment options for dysmenorrhea include lifestyle modifications, medications, and alternative therapies.
The dysmenorrhea market is an important part of the women's health industry. It is estimated that up to 90% of women experience some form of dysmenorrhea, making it a major concern for many. Companies in the dysmenorrhea market are focused on providing treatments and solutions to help women manage their symptoms. These include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Some of the companies in the dysmenorrhea market include Bayer AG, Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, and Allergan plc. These companies offer a variety of products and services to help women manage their dysmenorrhea symptoms. Show Less Read more